Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bioscalin is a line of topical hair care products, including ampules and shampoos, developed by the Italian company Giuliani and distributed in Austria by Pelpharma Handels. These products are marketed as cosmetic or over-the-counter (OTC) treatments for hair thinning and temporary hair loss. The formulations feature patented complexes such as Physiogenina and Biogenina, which are designed to support hair follicle health. Key ingredients include Methyl Iminooxothiazolidinyl Acetamido Dimethylthiophene Carboxylate, biotin, panthenol, and wheat protein, which work together to strengthen hair fibers and promote a healthy scalp environment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bioscalin.